Alteration of cerebrospinal fluid findings by partial treatment of bacterial meningitis.
D000293:Adolescent; D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002556:Cerebrospinal Fluid Proteins / Q000032:analysis; D002648:Child; D002675:Child, Preschool; D005260:Female; D005947:Glucose / Q000134:cerebrospinal fluid; D006801:Humans; D007223:Infant; D008297:Male; D008581:Meningitis / Q000134:cerebrospinal fluid* / Q000175:diagnosis / Q000188:drug therapy; D008583:Meningitis, Haemophilus / Q000134:cerebrospinal fluid; D008585:Meningitis, Meningococcal / Q000134:cerebrospinal fluid; D008586:Meningitis, Pneumococcal / Q000134:cerebrospinal fluid; D008587:Meningitis, Viral / Q000134:cerebrospinal fluid; D009504:Neutrophils / Q000134:cerebrospinal fluid; D010406:Penicillins / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D002556:Cerebrospinal Fluid Proteins; D010406:Penicillins; D013449:Sulfonamides; D000667:Ampicillin; D013752:Tetracycline; D005947:Glucose